245 related articles for article (PubMed ID: 30149561)
1. The Promise of Novel Biomarkers for Head and Neck Cancer from an Imaging Perspective.
Marcu LG; Reid P; Bezak E
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149561
[TBL] [Abstract][Full Text] [Related]
2. Cannot Target What Cannot Be Seen: Molecular Imaging of Cancer Stem Cells.
Marcu LG; Moghaddasi L; Bezak E
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675033
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia in head and neck cancer in theory and practice: a PET-based imaging approach.
Marcu LG; Harriss-Phillips WM; Filip SM
Comput Math Methods Med; 2014; 2014():624642. PubMed ID: 25214887
[TBL] [Abstract][Full Text] [Related]
4. Functional imaging for radiation treatment planning, response assessment, and adaptive therapy in head and neck cancer.
Bhatnagar P; Subesinghe M; Patel C; Prestwich R; Scarsbrook AF
Radiographics; 2013; 33(7):1909-29. PubMed ID: 24224586
[TBL] [Abstract][Full Text] [Related]
5. Imaging modalities in head-and-neck cancer patients.
Sham ME; Nishat S
Indian J Dent Res; 2012; 23(6):819-21. PubMed ID: 23649071
[TBL] [Abstract][Full Text] [Related]
6. Predicting treatment Response based on Dual assessment of magnetic resonance Imaging kinetics and Circulating Tumor cells in patients with Head and Neck cancer (PREDICT-HN): matching 'liquid biopsy' and quantitative tumor modeling.
Ng SP; Bahig H; Wang J; Cardenas CE; Lucci A; Hall CS; Meas S; Sarli VN; Yuan Y; Urbauer DL; Ding Y; Ikner S; Dinh V; Elgohari BA; Johnson JM; Skinner HD; Gunn GB; Garden AS; Phan J; Rosenthal DI; Morrison WH; Frank SJ; Hutcheson KA; Mohamed ASR; Lai SY; Ferrarotto R; MacManus MP; Fuller CD
BMC Cancer; 2018 Sep; 18(1):903. PubMed ID: 30231854
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of hypoxia in nasopharyngeal carcinoma with a focus on existing and novel hypoxia molecular imaging.
Yip C; Cook GJ; Wee J; Fong KW; Tan T; Goh V
Chin Clin Oncol; 2016 Apr; 5(2):24. PubMed ID: 27121884
[TBL] [Abstract][Full Text] [Related]
8. PET-MRI in the head and neck area: challenges and new directions.
Castelijns JA
Eur Radiol; 2011 Nov; 21(11):2425-6. PubMed ID: 21698462
[No Abstract] [Full Text] [Related]
9. [Molecular imaging of head and neck cancers : Perspectives of PET/MRI].
Stumpp P; Purz S; Sabri O; Kahn T
Radiologe; 2016 Jul; 56(7):588-96. PubMed ID: 27306200
[TBL] [Abstract][Full Text] [Related]
10. Tumor metabolism and perfusion in head and neck squamous cell carcinoma: pretreatment multimodality imaging with 1H magnetic resonance spectroscopy, dynamic contrast-enhanced MRI, and [18F]FDG-PET.
Jansen JF; Schöder H; Lee NY; Stambuk HE; Wang Y; Fury MG; Patel SG; Pfister DG; Shah JP; Koutcher JA; Shukla-Dave A
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):299-307. PubMed ID: 21236594
[TBL] [Abstract][Full Text] [Related]
11. Functional imaging of head and neck cancers.
Emonts P; Bourgeois P; Lemort M; Flamen P
Curr Opin Oncol; 2009 May; 21(3):212-7. PubMed ID: 19370804
[TBL] [Abstract][Full Text] [Related]
12. Multiparametric magnetic resonance imaging in mucosal primary head and neck cancer: a prospective imaging biomarker study.
Rumley CN; Lee MT; Holloway L; Rai R; Min M; Forstner D; Fowler A; Liney G
BMC Cancer; 2017 Jul; 17(1):475. PubMed ID: 28693449
[TBL] [Abstract][Full Text] [Related]
13. Correlation of p16 status, hypoxic imaging using [18F]-misonidazole positron emission tomography and outcome in patients with loco-regionally advanced head and neck cancer.
Trinkaus ME; Hicks RJ; Young RJ; Peters LJ; Solomon B; Bressel M; Corry J; Fisher R; Binns D; McArthur GA; Rischin D
J Med Imaging Radiat Oncol; 2014 Feb; 58(1):89-97. PubMed ID: 24529061
[TBL] [Abstract][Full Text] [Related]
14. [Current oncologic concepts and emerging techniques for imaging of head and neck squamous cell cancer].
Sadick M; Schoenberg SO; Hoermann K; Sadick H
Laryngorhinootologie; 2012 Mar; 91 Suppl 1():S27-47. PubMed ID: 22456918
[TBL] [Abstract][Full Text] [Related]
15. Head and neck cancer.
Walden MJ; Aygun N
Semin Roentgenol; 2013 Jan; 48(1):75-86. PubMed ID: 23158052
[TBL] [Abstract][Full Text] [Related]
16. Phase 1 trial of bevacizumab with concurrent chemoradiation therapy for squamous cell carcinoma of the head and neck with exploratory functional imaging of tumor hypoxia, proliferation, and perfusion.
Nyflot MJ; Kruser TJ; Traynor AM; Khuntia D; Yang DT; Hartig GK; McCulloch TM; Wiederholt PA; Gentry LR; Hoang T; Jeraj R; Harari PM
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):942-51. PubMed ID: 25659884
[TBL] [Abstract][Full Text] [Related]
17. SPECT and PET serve as molecular imaging techniques and in vivo biomarkers for brain metastases.
Palumbo B; Buresta T; Nuvoli S; Spanu A; Schillaci O; Fravolini ML; Palumbo I
Int J Mol Sci; 2014 Jun; 15(6):9878-93. PubMed ID: 24897023
[TBL] [Abstract][Full Text] [Related]
18. Extracranial head and neck neoplasms: role of imaging.
Petrou M; Mukherji SK
Cancer Treat Res; 2008; 143():93-117. PubMed ID: 18619215
[No Abstract] [Full Text] [Related]
19. Molecular imaging of hypoxia with radiolabelled agents.
Mees G; Dierckx R; Vangestel C; Van de Wiele C
Eur J Nucl Med Mol Imaging; 2009 Oct; 36(10):1674-86. PubMed ID: 19565239
[TBL] [Abstract][Full Text] [Related]
20. Validation of functional imaging as a biomarker for radiation treatment response.
Jentsch C; Beuthien-Baumann B; Troost EG; Shakirin G
Br J Radiol; 2015 Jul; 88(1051):20150014. PubMed ID: 26083533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
